Edgewise Therapeutics’ Phase 2 HCM data put systolic function into sharper focus
Find out how Edgewise Therapeutics’ EDG-7500 data could reshape HCM drug development as Phase 3 questions emerge.
Pharma & Biotech
Pharma & Biotech
Can Curi Bio’s Curiverse solve the scalability problem in human-relevant drug discovery?
Human-relevant drug screening is hitting a scale problem. Curi Bio’s Curiverse aims to turn 3D tissue models into industrial workflows.
Medical Devices & Diagnostics
What Viz.ai’s latest hypertrophic cardiomyopathy studies reveal about the future of cardiac AI
Viz.ai’s new HCM studies suggest AI-ECG could improve detection and follow-up. Read what this changes for cardiology workflows and adoption.